Skip to main content
lexblog.com/lib/9PRM0STNviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "CMS Innovation Center Announces Sickle Cell Disease Focus under Cell and Gene Therapy Access Model",
    "url": "https://www.lexblog.com/2024/02/06/cms-innovation-center-announces-sickle-cell-disease-focus-under-cell-and-gene-therapy-access-model-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-9PRM0STN",
        "url": "https://www.lexblog.com/lib/9PRM0STN/"
    },
    "datePublished": "2024-02-06T19:55:10-05:00",
    "dateModified": "2026-02-13T13:19:31-05:00",
    "author": {
        "@type": "Person",
        "name": "Troy A. Barsky, Allison Kwon"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Crowell & Moring LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Trends in Transformation",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.openlegalblogarchive.org/2024/02/06/cms-innovation-center-announces-sickle-cell-disease-focus-under-cell-and-gene-therapy-access-model/",
    "sourceStability": "may-move"
}